Pharmacological reduction of lipid hydroperoxides as a potential modulator of sarcopenia
Jacob L. Brown(Florida State University), Holly Van Remmen(Oklahoma Medical Research Foundation)
Cited by 5
Related Papers
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging
|Physiological Genomics|2003|733
The overexpression of major antioxidant enzymes does not extend the lifespan of mice
|Aging Cell|2008|345
The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging
|Aging Cell|2015|321
Protein imbalance in the development of skeletal muscle wasting in tumour‐bearing mice
|Journal of Cachexia Sarcopenia and Muscle|2018|112
Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia
|Journal of Cachexia Sarcopenia and Muscle|2021|79